PI3K

Genomic heterogeneity and efficacy of PI3K pathway inhibitors in patients with gynaecological cancer
Victor Rodriguez-Freixinos, Fiorella Ruiz-Pace, Lorena Fariñas-Madrid, Ana Christina Garrido-Castro, Guillermo Villacampa, Paolo Nuciforo, Ana Vivancos, Rodrigo Dienstmann, Ana Oaknin

ESMO Open Mar 2019, 4 (2) e000444; DOI: 10.1136/esmoopen-2018-000444
Indolent peritoneal mesothelioma: PI3K-mTOR inhibitors as a novel therapeutic strategy
Saoirse O Dolly, Cristina Migali, Nina Tunariu, Chiara Della-Pepa, Shelize Khakoo, Steve Hazell, Johann S de Bono, Stanley B Kaye, Susana Banerjee

ESMO Open Apr 2017, 2 (1) e000101; DOI: 10.1136/esmoopen-2016-000101

Main menu